Journal article icon

Journal article

Microenvironment tumor metabolic interactions highlighted by qMSI: Application to the tryptophan-kynurenine pathway in immuno-oncology

Abstract:
Inhibition of NK and effector T-cell functions and activation of regulatory cell populations are the main immunosuppressive effects of indoleamine-2,3-dioxygenase1 (IDO1). By converting tryptophan (Trp) into kynurenine (Kyn), IDO1 is involved in the immune response homeostasis, and its dysregulated expression is described in immune-related pathologies, as tumors that hijack it to evade immune destruction. Thereby, IDO1 inhibitors are being developed to stimulate antitumor immune responses. Existing and standard quantitation methods of IDO1 substrate and metabolite(s) are based on the total level of Trp and its metabolites determined by liquid chromatography tandem mass spectrometry analysis in human plasma, cerebrospinal fluid, and brain. Here, we describe the detection, localization, and absolute quantitation of Trp and Kyn by quantitative mass spectrometry imaging (qMSI) in transfected murine tumor models expressing various levels of IDO1. Myeloid, glycolysis metabolic signatures, and correlation between IDO1 expression and Trp to Kyn conversion are also shown. High-definition IDO1 and GCN2 immunostainings overlaid with Kyn molecular images underline the tumor metabolism and heterogeneity. The development of immunotherapies such as IDO1 inhibitors requires a deep understanding of the immune system, the interplay of cancer cells, and biomarker characterization. Our data underline that qMSI allows the study of the spatial distribution and quantitation of endogenous immune metabolites for biology and pharmacology studies.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1177/2472555217712659

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Oxford Ludwig Institute
Role:
Author
ORCID:
0000-0002-4995-3270


More from this funder
Grant:
TumorMicroenvironment Characterization
ApplicationsinImmuno-oncology(A1408004N
More from this funder
Grant:
ApplicationsinImmuno-oncology(A1408004N
TumorMicroenvironment Characterization
More from this funder
Grant:
ApplicationsinImmuno-oncology(A1408004N
TumorMicroenvironment Characterization


Publisher:
SAGE Publications
Journal:
SLAS DISCOVERY: Advancing Life Sciences R&D More from this journal
Volume:
22
Issue:
10
Pages:
1182-1192
Publication date:
2017-05-30
Acceptance date:
2017-05-05
DOI:
EISSN:
2472-5560
ISSN:
2472-5552
Pmid:
28557618


Language:
English
Keywords:
Pubs id:
pubs:809047
UUID:
uuid:0e83c18c-cd5c-4dff-b3a4-3faf463ce189
Local pid:
pubs:809047
Source identifiers:
809047
Deposit date:
2017-12-11

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP